Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
المؤلفون الرئيسيون: | Flossmann, O, Jones, R, Jayne, DR, Luqmani, R |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2006
|
مواد مشابهة
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
حسب: Mukhtyar, C, وآخرون
منشور في: (2006) -
Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
حسب: Mukhtyar, C, وآخرون
منشور في: (2008) -
Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
حسب: Saket Jha, وآخرون
منشور في: (2019-01-01) -
Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
حسب: Zhi-Ying Li, وآخرون
منشور في: (2020-08-01) -
A Case of Postcoronavirus Disease 2019 Antineutrophil Cytoplasmic Antibody-associated Vasculitis Successfully Treated with Rituximab
حسب: Mahmoud M. Mohamed, وآخرون
منشور في: (2023-07-01)